Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07476053 · ClinicalTrials.gov registry record · NA

Light Exposure, Migraine Outcomes, and Sleep Quality

A NA study of Sleep and Migraine Headache, sponsored by Arizona State University.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07476053: Recruiting NA study of Sleep and Migraine Headache, sponsored by Arizona State University.

NCT07476053 is a NA study of Sleep and Migraine Headache that is actively recruiting participants, run by Arizona State University. The registered enrollment target is 20 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07476053, a NA study of Sleep and Migraine Headache, is actively recruiting participants, sponsored by Arizona State University.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the relationship between daily light exposure patterns, sleep quality, and migraine characteristics in adults with migraine, with and without photophobia, across an 8-week study period.

Primary Outcome

Number of migraine days per 28-day period as recorded in daily electronic headache diaries. A migraine day is defined as a calendar day with a self-reported migraine meeting International Classification of Headache Disorders (ICHD-3) criteria. The primary analysis will compare the 4-week baseline period to the 4-week intervention period within participants.

Interventions

  • OTHER Ambient Lighting Condition

Study Locations (1)

Arizona

  • ASU DeSmart Lab - Tempe

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-03
Est. Completion 2027-03
Phase NA
Arizona State University

187 total trials

What NCT07476053 shows while recruiting

NCT07476053 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Ambient Lighting Condition is the first listed.

NCT07476053 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT07476053 about?

NCT07476053 is a clinical study titled "Light Exposure, Migraine Outcomes, and Sleep Quality". The purpose of this study is to examine the relationship between daily light exposure patterns, sleep quality, and migraine characteristics in adults with migraine, with and without photophobia, across an 8-week study period.

What is the current status of trial NCT07476053?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-03. Estimated completion is 2027-03.

What conditions does trial NCT07476053 study?

This clinical trial studies the following conditions: Sleep, Migraine Headache, Photophobia.

What interventions are being tested in trial NCT07476053?

The interventions under investigation include: Ambient Lighting Condition (OTHER).

Who is sponsoring clinical trial NCT07476053?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07476053 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07476053's enrollment target sits among peer trials

20 134th of 151 higher than 12 of 151 other Sleep trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07476053, the US trial registry maintained by the National Library of Medicine. NCT07476053 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.